Listed

Viking Therapeutics, Inc.

VKTXNasdaqCIK 1607678HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$132.6m, Q2 FY2026
Net income−$128.0m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.0Revenue, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure0.0Revenue, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Research and development$m18.4Research and development, Q3 FY2023, three months to 2023-09-30$18.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure20.5Research and development, Q4 FY2023, three months to 2023-12-31$20.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure24.1Research and development, Q1 FY2024, three months to 2024-03-31$24.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure23.8Research and development, Q2 FY2024, three months to 2024-06-30$23.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure22.8Research and development, Q3 FY2024, three months to 2024-09-30$22.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure31.0Research and development, Q4 FY2024, three months to 2024-12-31$31.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure41.4Research and development, Q1 FY2025, three months to 2025-03-31$41.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure60.2Research and development, Q2 FY2025, three months to 2025-06-30$60.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure90.0Research and development, Q3 FY2025, three months to 2025-09-30$90.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure153Research and development, Q4 FY2025, three months to 2025-12-31$153.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure150Research and development, Q1 FY2026, three months to 2026-03-31$150.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure116Research and development, Q2 FY2026, three months to 2026-06-30$115.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Operating income$m(27.3)Operating income, Q3 FY2023, three months to 2023-09-30−$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure(29.3)Operating income, Q4 FY2023, three months to 2023-12-31−$29.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(34.1)Operating income, Q1 FY2024, three months to 2024-03-31−$34.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure(34.1)Operating income, Q2 FY2024, three months to 2024-06-30−$34.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure(36.6)Operating income, Q3 FY2024, three months to 2024-09-30−$36.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure(46.2)Operating income, Q4 FY2024, three months to 2024-12-31−$46.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(55.5)Operating income, Q1 FY2025, three months to 2025-03-31−$55.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(74.6)Operating income, Q2 FY2025, three months to 2025-06-30−$74.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure(98.6)Operating income, Q3 FY2025, three months to 2025-09-30−$98.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure(165)Operating income, Q4 FY2025, three months to 2025-12-31−$164.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(164)Operating income, Q1 FY2026, three months to 2026-03-31−$164.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(133)Operating income, Q2 FY2026, three months to 2026-06-30−$132.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(22.5)Net income, Q3 FY2023, three months to 2023-09-30−$22.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure(24.6)Net income, Q4 FY2023, three months to 2023-12-31−$24.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(27.4)Net income, Q1 FY2024, three months to 2024-03-31−$27.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure(22.3)Net income, Q2 FY2024, three months to 2024-06-30−$22.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure(24.9)Net income, Q3 FY2024, three months to 2024-09-30−$24.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure(35.4)Net income, Q4 FY2024, three months to 2024-12-31−$35.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(45.6)Net income, Q1 FY2025, three months to 2025-03-31−$45.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(65.6)Net income, Q2 FY2025, three months to 2025-06-30−$65.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure(90.8)Net income, Q3 FY2025, three months to 2025-09-30−$90.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure(158)Net income, Q4 FY2025, three months to 2025-12-31−$157.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(158)Net income, Q1 FY2026, three months to 2026-03-31−$158.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(128)Net income, Q2 FY2026, three months to 2026-06-30−$128.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Diluted EPS$ per share(0.23)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figurenot reported(0.26)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure(0.20)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure(0.22)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figurenot reported(0.41)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(0.58)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure(0.81)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figurenot reported(1.37)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(1.10)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Basic EPS$ per share(0.23)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figurenot reported(0.26)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure(0.20)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure(0.22)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figurenot reported(0.41)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(0.58)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure(0.81)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figurenot reported(1.37)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(1.10)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure

Balance sheet

Cash and equivalents$125.8m, Q2 FY2026
Shareholders' equity$408.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m37.2Cash and equivalents, Q3 FY2023, at 2023-09-30$37.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-10-25, accession 0000950170-23-055259.Report this figure55.5Cash and equivalents, FY2023, at 2023-12-31$55.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-26, accession 0000950170-25-027824.Report this figure196Cash and equivalents, Q1 FY2024, at 2024-03-31$195.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-04-25, accession 0000950170-24-047833.Report this figure43.9Cash and equivalents, Q2 FY2024, at 2024-06-30$43.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-07-24, accession 0000950170-24-086111.Report this figure50.3Cash and equivalents, Q3 FY2024, at 2024-09-30$50.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure26.7Cash and equivalents, FY2024, at 2024-12-31$26.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-11, accession 0001193125-26-046876.Report this figure37.9Cash and equivalents, Q1 FY2025, at 2025-03-31$37.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure33.9Cash and equivalents, Q2 FY2025, at 2025-06-30$33.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure100Cash and equivalents, Q3 FY2025, at 2025-09-30$100.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure166Cash and equivalents, FY2025, at 2025-12-31$165.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure118Cash and equivalents, Q1 FY2026, at 2026-03-31$118.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure126Cash and equivalents, Q2 FY2026, at 2026-06-30$125.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Current assets$m381Current assets, Q3 FY2023, at 2023-09-30$381.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-25, accession 0000950170-23-055259.Report this figure367Current assets, FY2023, at 2023-12-31$367.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-26, accession 0000950170-25-027824.Report this figure966Current assets, Q1 FY2024, at 2024-03-31$966.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-25, accession 0000950170-24-047833.Report this figure946Current assets, Q2 FY2024, at 2024-06-30$945.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-07-24, accession 0000950170-24-086111.Report this figure937Current assets, Q3 FY2024, at 2024-09-30$936.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure907Current assets, FY2024, at 2024-12-31$907.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-11, accession 0001193125-26-046876.Report this figure866Current assets, Q1 FY2025, at 2025-03-31$866.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure827Current assets, Q2 FY2025, at 2025-06-30$827.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure739Current assets, Q3 FY2025, at 2025-09-30$738.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure716Current assets, FY2025, at 2025-12-31$715.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure608Current assets, Q1 FY2026, at 2026-03-31$608.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure518Current assets, Q2 FY2026, at 2026-06-30$517.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Total assets$m383Total assets, Q3 FY2023, at 2023-09-30$382.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-25, accession 0000950170-23-055259.Report this figure368Total assets, FY2023, at 2023-12-31$368.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-26, accession 0000950170-25-027824.Report this figure968Total assets, Q1 FY2024, at 2024-03-31$967.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-25, accession 0000950170-24-047833.Report this figure947Total assets, Q2 FY2024, at 2024-06-30$946.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-07-24, accession 0000950170-24-086111.Report this figure938Total assets, Q3 FY2024, at 2024-09-30$937.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure908Total assets, FY2024, at 2024-12-31$908.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-11, accession 0001193125-26-046876.Report this figure867Total assets, Q1 FY2025, at 2025-03-31$867.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure828Total assets, Q2 FY2025, at 2025-06-30$827.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure739Total assets, Q3 FY2025, at 2025-09-30$739.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure716Total assets, FY2025, at 2025-12-31$715.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure608Total assets, Q1 FY2026, at 2026-03-31$608.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure522Total assets, Q2 FY2026, at 2026-06-30$521.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Current liabilities$m13.4Current liabilities, Q3 FY2023, at 2023-09-30$13.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-25, accession 0000950170-23-055259.Report this figure19.1Current liabilities, FY2023, at 2023-12-31$19.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-26, accession 0000950170-25-027824.Report this figure32.8Current liabilities, Q1 FY2024, at 2024-03-31$32.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-25, accession 0000950170-24-047833.Report this figure25.1Current liabilities, Q2 FY2024, at 2024-06-30$25.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-07-24, accession 0000950170-24-086111.Report this figure25.7Current liabilities, Q3 FY2024, at 2024-09-30$25.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure27.4Current liabilities, FY2024, at 2024-12-31$27.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-11, accession 0001193125-26-046876.Report this figure19.6Current liabilities, Q1 FY2025, at 2025-03-31$19.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure32.0Current liabilities, Q2 FY2025, at 2025-06-30$32.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure26.1Current liabilities, Q3 FY2025, at 2025-09-30$26.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure76.7Current liabilities, FY2025, at 2025-12-31$76.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure106Current liabilities, Q1 FY2026, at 2026-03-31$106.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure110Current liabilities, Q2 FY2026, at 2026-06-30$109.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Total liabilities$m14.4Total liabilities, Q3 FY2023, at 2023-09-30$14.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-10-25, accession 0000950170-23-055259.Report this figure20.1Total liabilities, FY2023, at 2023-12-31$20.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-26, accession 0000950170-25-027824.Report this figure33.6Total liabilities, Q1 FY2024, at 2024-03-31$33.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-25, accession 0000950170-24-047833.Report this figure25.9Total liabilities, Q2 FY2024, at 2024-06-30$25.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-07-24, accession 0000950170-24-086111.Report this figure26.4Total liabilities, Q3 FY2024, at 2024-09-30$26.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure28.0Total liabilities, FY2024, at 2024-12-31$28.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-11, accession 0001193125-26-046876.Report this figure20.1Total liabilities, Q1 FY2025, at 2025-03-31$20.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure32.4Total liabilities, Q2 FY2025, at 2025-06-30$32.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure26.4Total liabilities, Q3 FY2025, at 2025-09-30$26.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure76.7Total liabilities, FY2025, at 2025-12-31$76.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure106Total liabilities, Q1 FY2026, at 2026-03-31$106.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure114Total liabilities, Q2 FY2026, at 2026-06-30$113.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure
Shareholders' equity$m368Shareholders' equity, Q3 FY2023, at 2023-09-30$368.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-10-25, accession 0000950170-23-055259.Report this figure348Shareholders' equity, FY2023, at 2023-12-31$348.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-26, accession 0000950170-25-027824.Report this figure934Shareholders' equity, Q1 FY2024, at 2024-03-31$933.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-04-25, accession 0000950170-24-047833.Report this figure921Shareholders' equity, Q2 FY2024, at 2024-06-30$921.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-07-24, accession 0000950170-24-086111.Report this figure911Shareholders' equity, Q3 FY2024, at 2024-09-30$911.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure880Shareholders' equity, FY2024, at 2024-12-31$880.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-11, accession 0001193125-26-046876.Report this figure847Shareholders' equity, Q1 FY2025, at 2025-03-31$846.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure795Shareholders' equity, Q2 FY2025, at 2025-06-30$795.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure713Shareholders' equity, Q3 FY2025, at 2025-09-30$713.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure639Shareholders' equity, FY2025, at 2025-12-31$639.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure502Shareholders' equity, Q1 FY2026, at 2026-03-31$501.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure408Shareholders' equity, Q2 FY2026, at 2026-06-30$408.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure

Cash flow

Operating cash flow−$125.2m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(19.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-23, accession 0000950170-24-116708. Derived: 9-month figure less the 6-month figure.Report this figure(17.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(6.1)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure(28.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$28.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-23, accession 0000950170-25-097950. Derived: 6-month figure less the 3-month figure.Report this figure(22.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$22.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-23, accession 0001193125-25-247059. Derived: 9-month figure less the 6-month figure.Report this figure(31.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$31.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(52.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$52.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(47.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$47.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001193125-26-324219. Derived: 6-month figure less the 3-month figure.Report this figure(94.0)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$94.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-23, accession 0001193125-25-247059. Derived: 9-month figure less the 6-month figure.Report this figure(85.3)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$85.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-11, accession 0001193125-26-046876. Derived: 12-month figure less the 9-month figure.Report this figure(114)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$114.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure(125)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$125.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001193125-26-324219. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)116.26m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares76.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3076,505,383 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-10-25, accession 0000950170-23-055259.Report this figure78.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3178,351,826 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-25, accession 0000950170-24-047833.Report this figure99.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3099,009,710 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-07-24, accession 0000950170-24-086111.Report this figure99.8Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3099,845,733 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-23, accession 0000950170-24-116708.Report this figure103Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31103,457,305 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-04-24, accession 0000950170-25-058129.Report this figure110Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30110,390,171 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-07-23, accession 0000950170-25-097950.Report this figure111Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30110,910,704 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure112Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31112,069,078 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure112Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30112,134,425 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure112Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30112,319,770 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-23, accession 0001193125-25-247059.Report this figure116Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31115,568,078 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-04-30, accession 0001193125-26-193315.Report this figure116Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30116,262,723 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure

Shares outstanding: 116.65mShares outstanding, period not labelled, at 2026-07-15116,652,937 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-07-29, accession 0001193125-26-324219.Report this figure at Jul 15, 2026, from the cover of the 10-Q filed Jul 29, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.